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Albumin is the most abundant plasmaprotein serving
multiple functions as a carrier of metabolites, hormones,
vitamins, and drugs, as an acid/base buffer, as antioxidant
and by supporting the oncotic pressure and volume of the
blood. The presence of albumin in urine is considered to be
the result of the balance between glomerular filtration and
tubular reabsorption. Albuminuria has been accepted as an
independent risk factor and a marker for renal as well as
cardiovascular disease, and during the past decade, evidence
has suggested that albumin itself may cause progression of
renal disease. Thus, the reduction of proteinuria and, in
particular, albuminuria has become a target in itself to
prevent deterioration of renal function. Studies have shown
albumin and its ligands to induce expression of inflammatory
and fibrogenic mediators, and it has been hypothesized that
increased filtration of albumin causes excessive tubular
reabsorption, resulting in inflammation and fibrosis, resulting
in the loss of renal function. In addition, it is known that
tubular dysfunction in itself may cause albuminuria owing to
decreased reabsorption of filtered albumin, and, recently, it
has been suggested that significant amounts of albumin
fragments are excreted in the urine as a result of tubular
degradation. Thus, although both tubular and glomerular
dysfunction influences renal handling of albumin, it appears
that tubular reabsorption plays a central role in mediating
the effects of albumin on renal function. The present paper
will review the mechanisms for tubular albumin uptake and
the possible implications for the development of renal
disease.
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Albumin is synthesized in the liver and is the most abundant
plasma protein. It is an anionic, flexible, heart-shaped
molecule with a molecular weight of B65 kDa.1 Although it
is not essential to life, a number of important and very diverse
functions have been ascribed to this protein, including the
maintenance of the oncotic pressure and blood volume, acid/
base buffer functions, antioxidant functions and the transport
of a number of different substances like fatty acids, bilirubin,
ions such as Ca2þ and Mg2þ , drugs, hormones, and
lipophilic as well as hydrophilic vitamins, for example, vitamin
A, riboflavin, vitamin B6, ascorbic acid, and folate. Both serum
and urinary albumin levels are important prognostic indica-
tors in renal disease. Hypoalbuminemia in renal disease is
associated with increased mortality and has been ascribed both
to malnutrition and to inflammation, whereas the level of
albumin in the urine is directly related to the progression of
renal disease, with no known lower threshold to the relation-
ship. These findings have prompted a strong interest in the
mechanisms for renal handling of albumin and in the effects of
albumin on renal function. Albumin filtered in the glomeruli
is considered to be the major source of urinary albumin.
Filtration of albumin is followed by tubular reabsorption, and
thus the resulting albuminuria reflects the combined con-
tribution of these two processes. Dysfunction of both these
processes may result in increased excretion of albumin, and
both glomerular injury and tubular impairment have been
implicated in the initial events leading to proteinuria. Multiple
theories have emerged to explain the clinical observation that
once renal damage has reached a certain level, renal function
will decline independent of the primary events initiating the
process. Within the last decade there has been considerable
focus on the potential pathogenic role of proteinuria,
including albuminuria. The hypothesis is based on the
observations that the rate of progression in various renal
diseases correlates with the degree of proteinuria and on
studies using tubular cells in vitro showing that high
concentrations of proteins induce the production of inflam-
matory and fibrogenic mediators. This points to a central role
of the mechanisms regulating tubular uptake of albumin.
Although new pathways of tubular albumin reabsorption have
been hypothesized recently, receptor-mediated endocytosis has
been extensively studied and characterized as an essential
mechanism for proximal tubule uptake of albumin. The
present review will include recent advances in the under-
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standing of this process and the potential implications for
albumin-induced changes in renal tubular function.
GLOMERULAR FILTRATION OF ALBUMIN
The amount of albumin normally filtered in the glomeruli
has been estimated using various techniques, including
micropuncture of rats and dogs, estimating the concentration
of albumin in the ultrafiltrate between 1 and 50 mg/ml.2 This
corresponds to a filtered load of albumin between 170 mg
and 9 g/24 h in normal humans. Inhibition of tubular
albumin uptake in humans by lysine suggested filtration of
at least B281 mg/min, corresponding to B400 mg/24 h.3
Similar studies in lysine-treated rats resulted in the excretion
of 2.5–25 mg/24 h4,5 corresponding to 0.7–7 g/24 h in humans.
These studies were based on immunoassays for detecting
urinary albumin. It was recently suggested, based on the
excretion of radiolabelled albumin and high-performance
liquid chromatography, that significant amounts of albumin
fragments are excreted in rat and human urine, possibly
resulting from tubular degradation of filtered albumin,
followed by luminal secretion of albumin fragments.6–9 Such
fragments cannot be detected by conventional analyses,
including radioimmunoassay. These studies, implicating a
much greater amount of filtered albumin in the normal
kidney, are still controversial. Renal catabolism and excretion
of as much as 6.5 mg/100 g body weight/h in normal rats
were estimated,8 apparently exceeding normal rat liver
albumin synthesis rate.10 The findings are also in contrast
to reports on urine protein excretion in Fanconi patients
using proteomics.11 Thus, although the albumin filtration
rate still remains controversial, it is clear that a significant
amount of albumin is filtered and subsequently reabsorbed
by the renal tubules.
TUBULAR REABSORPTION OF ALBUMIN
Proximal tubular reabsorption of albumin by endocytosis was
demonstrated almost 40 years ago.12,13 Endocytic uptake of
proteins has been intensively studied and includes both
nonspecific fluid-phase endocytosis as well as receptor-
mediated endocytosis. In the kidney, proximal tubule fluid-
phase endocytosis of solutes is negligible.2,14 Receptor-
mediated endocytosis, as originally described,15 involves the
specific binding of a ligand to receptors in the apical plasma
membrane. The receptor–ligand complex is internalized by
invagination of the plasma membrane caused by adaptor
molecule-mediated formation of a cytoplasmic coat.16–18 In
clathrin-coated endocytosis, binding of adaptor molecules to
the cytoplasmic tail of transmembrane receptors involves a
characteristic NPXY motif17 identified in a number of
endocytic receptors. Internalization is followed by dissocia-
tion of the invaginations from the plasma membrane forming
vesicles. While the cytoplasmic coat dissociates, vesicles may
fuse with other newly formed vesicles, or with an existing
pool of larger vesicles, followed by acidification of the
intravesicular lumen and the dissociation of the ligand from
the receptor. The ligand may be further transported into
lysosomes for storage or degradation, or into the cytosol for
further processing/transport. The receptor is recycled back to
the luminal membranes through a recycling compartment
known as dense apical tubules,19 but may also be transported
to lysosomes for degradation. Albumin binding sites on
isolated proximal tubule segments and cells in vitro have been
identified,14,20–22 and several receptors for tubular uptake of
albumin have been identified. These include the multiligand
receptors megalin and cubilin, responsible for the constitu-
tive uptake of a vast variety of filtered plasma proteins.
MEGALIN
Megalin is a multifunctional, endocytic receptor belonging to
the low-density lipoprotein receptor family. It binds a
number of structurally very different proteins. Megalin was
originally identified as the antigen in Heymann nephritis, a
rat model of membranous glomerulonephritis.23 It contains a
large amino-terminal, extracellular domain, a single trans-
membrane domain and a short carboxy-terminal cytoplasmic
tail (Figure 1). The latter harbors two NPXY sequences
mediating the binding to adaptor proteins and the clustering
into clathrin-coated pits,24–27 in addition to several Src
homology 3 and one Src homology 2 recognition sites.24,25
The extracellular domain is composed of four cysteine-rich
clusters of low-density lipoprotein receptor type A repeats
constituting the ligand binding regions separated and
followed by a total of 17 epidermal growth factor (EGF)-
type repeats and eight spacer regions containing YWTD
repeats. Generally, binding to megalin is Ca2þ dependent,
and megalin itself binds calcium very strongly.28 Site-directed
mutations of basic amino-acid residues in aprotinin, a ligand
for megalin, decrease the affinity for the receptor, suggesting
that binding is favored by cationic sites on the ligands.29
Many ligands are anionic proteins, indicating that the
distribution of charge rather than the overall isoelectric
point is important for binding.
Renal expression
Megalin is heavily expressed in the kidney proximal tubule
brush-border and luminal endocytic apparatus,23,28,30–32 as
well as in lysosomal structures revealing smaller amounts of
immmunoreactive megalin. Megalin has also been identified
in the glomerular podocytes of Lewis rats,33 but not in other
rat strains or other species. Extrarenal expression of megalin
includes a number of other absorptive epithelia, including
the ileum34,35 and the rodent yolk sac36 (reviewed in
Christensen and Birn37).
Much of our knowledge on the functions of megalin is
based on data recovered from the study of megalin-deficient
mice.38,39 Megalin-deficient, proximal tubule cells are char-
acterized by a loss of endocytic invaginations, vesicles, and
the membrane recycling compartment, dense apical tu-
bules.40 So far, no significant changes in transport of water,
electrolytes, glucose, or amino acids have been described in
the megalin-deficient mice; however, an increased amount of
several low-molecular weight serum proteins has been
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identified in the urine. The normal expression of megalin is
dependent on receptor-associated protein (RAP)41 serving as
a chaperone-protecting newly synthesized receptor from the
early binding of ligands and possibly involved in folding of
the receptor.42–46 RAP binds megalin with high affinity within
the endoplasmic reticulum and functions as an intracellular
ligand inhibiting the binding of most other ligands to
megalin.
A number of diseases characterized by proteinuria reveal
decreased renal megalin expression.47–49 These include Dent’s
disease, which is caused by mutations in the renal chloride
channel ClC-5.50 Disruption of ClC-5 impairs proximal
tubule endocytosis, and causes a reduction in megalin
expression.49,51–53 Analyses on megalin knockout mice and
patients with low-molecular weight and tubular proteinuria,
including Dent’s disease, have shown several analogies.51,54
CUBILIN
Cubilin is a multiligand, endocytic receptor also known as
the intestinal intrinsic factor (IF)-B12 receptor.
55 Cubilin was
originally identified as the target of teratogenic antibodies in
rats.56 It is a 460 kDa protein with little structural homology
to known, endocytic receptors (Figure 1).57–59 Cubilin is
composed of an initial 110-amino-acid region necessary for
membrane anchoring of the receptor60, followed by eight
EGF-like repeats and 27 complement subcomponents C1r/
C1s, Uegf, and bone morphogenic protein-1 (CUB)
domains.61 No transmembrane domain has been identified
in cubilin consistent with the observation that it is released
from renal cortical membranes by nonenzymatic and non-
solubilizing procedures.58 The many CUB domains in cubilin
support the ability of the receptor to bind a variety of ligands.
Binding sites for selected ligands have been partially localized.
Albumin, along with IF-B12, binding sites have been
identified in a 113-residue amino-terminus, which includes
the EGF-type repeats. Although IF-B12 inhibits binding of
albumin to cubilin, the binding sites for the two proteins do
not appear to be identical within this domain,62 and an
additional binding site for IF-B12 has been identified in CUB
domains 5–8.60 RAP binds to CUB domains 13–14,35,60
although its role for the processing of this receptor is
unknown. Megalin also binds to cubilin, possibly within the
amino-terminal region including CUB domains 1 and 2,34
supporting an interaction between the two receptors as
discussed below.
Renal expression
Cubilin is highly expressed in the renal proximal tubule
brush-border and endocytic apparatus (Figure 2).36,55,63 As
with megalin, immunoreactive cubilin can also be identified
in lysosomes.55 Normal expression of cubilin is dependent on
amnionless (AMN), a B45 kDa, transmembrane protein
(Figure 1) identified as an important factor for the normal
development of the middle portion of the primitive streak in
mice.64 AMN co-localize with cubilin in kidney proximal
tubule,65 interacts with the EGF-type repeats of cubilin and is
essential for normal translocation of the cubilin–AMN
complex from the ER to the plasmamembrane and for the
subsequent endocytosis.65,66 Dogs with a mutation in the
AMN gene as well as AMN-deficient mouse epithelial cells
reveal defective apical insertion of cubilin.67–71 Mutations in
either the cubilin or the AMN gene have been identified in
Imerslund–Gra¨sbeck disease,72,73 a rare, inherited vitamin B12
deficiency syndrome characterized by defective intestinal
absorption of IF-B12.
74–77 Two affected Finnish families
revealed a one-amino-acid substitution in CUB domain 8
affecting the binding of IF-B12 to cubilin or, alternatively, a
point mutation expected to activate a cryptic intronic splice
site causing an in-frame insertion and introducing stop
codons predicting a truncation of the receptor in CUB
CUB domain
Complement-type repeat
EGF-type repeat
Spacer region containing YWTD
Transmembrane domain
NPXY motifs and VENQNY motif
COOH COOH
Luminal
plasmamembrane
NPXY
NPXY
Cubilin
Amnionless
NH2
Megalin
NH2
VENQNY
NH2
Figure 1 | Schematic representation showing the structure of
megalin, cubilin, and AMN. Megalin is a 4600-amino-acid trans-
membrane protein with a non-glycosylated molecular weight of
517 kDa. The extracellular domain (B4400 amino acids) contains four
cysteine-rich clusters of low-density lipoprotein receptor type A
repeats constituting the ligand binding regions separated and
followed by a total of 17 EGF-type repeats and eight spacer regions
containing YWTD repeats. A single transmembrane domain (22
amino acids) is followed by the cytoplasmic tail (213 amino acids),
which contains two NPXY sequences and one VENQNY sequence in
addition to several Src homology 3 and one Src homology 2
recognition sites. Cubilin is a 3600-amino-acid protein with no
transmembrane domain and a non-glycosylated molecular weight of
B400 kDa. The extracellular domain contains 27 CUB domains
constituting molecular basis for interaction with multiple other
proteins. The CUB domains are preceded by a stretch of 110 amino
acids followed by eight EGF-type repeats. The amino-terminal region
contains a potential palmitoylation site and an amphipathic helix
structure with some similarity to the lipid binding regions of
apolipoproteins. AMN is a 434-amino-acid, single-transmembrane
protein with a non-glycosylated molecular weight ofB46 kDa. It has
no known, closely related proteins, but a cysteine-rich stretch of 70
amino acids in the extracellular domain has similarity to modules
present in a small group of proteins serving as bone morphogenic
protein inhibitors. Both AMN and megalin bind cubilin and studies
indicate that both are involved in the endocytosis of this receptor.
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domain 6.78 While the patient with the latter mutation has
overt albuminuria, patients with amino-acid substitution
reveal varying degrees of proteinuria ranging from little or
no, to clearcut.77 Affected members of three Norwegian
families, shown to have a nucleotide deletion causing the
introduction of an early stop codon in the AMN gene,73 were
all previously characterized, and had proteinuria at the time
of diagnosis.74 The proteinuria observed in these patients
support a role for cubilin in renal tubular protein reabsorp-
tion, and it may be hypothesized that the difference in the
degree of albuminuria depends on the type of mutation and
reflects the extent of inactivation of cubilin function, in
particular whether the mutation affects the multiligand
properties or only the IF-B12 binding site.
OTHER RECEPTORS
Additional renal albumin receptors have been suggested
including 55 and 31 kDa proteins identified by albumin-
affinity chromatography and localized by immunocytochem-
istry. The sizes of these proteins are comparable to albumin
binding proteins identified in endothelial cells and fibro-
blasts.79–81 Antibody cross-reactivity suggested that the low-
molecular weight receptors identified in rat proximal tubule
are, in fact, fragments of cubilin,70 although the presence of
multiple, structurally different albumin binding proteins
cannot be excluded. The exact localization and functional
importance of these, however, remains to be established.
MEGALIN- AND CUBILIN-MEDIATED UPTAKE OF ALBUMIN
Cubilin plays an important role in normal proximal tubule
endocytic reabsorption of filtered albumin (Figure 3).
Albumin binds to cubilin with an estimated Kd B0.6 mM.
70
Furthermore, in dogs with a dysfunction of AMN and a
resulting defective apical expression of cubilin, urinary
albumin excretion is significantly increased and associated
with the lack of tubular endocytosis of albumin, demon-
strated by the absent labelling for albumin in endocytic
vesicles (Figure 2).70 Similarly, patients with Imerlund–Gra¨s-
beck disease may also have albuminuria, supporting a role of
cubilin. Albumin uptake in opossum kidney (OK) cells was
inhibited by IF-B12, and anti-cubilin antibodies.
82 The
inhibitory constant for IF-B12 was 1.7 mM in line with the
finding that IF-B12 and albumin both may bind to the same
113-residue amino-terminus of cubilin.62 Megalin-deficient
mice also reveal an increase in urinary albumin excretion,70
suggesting that megalin is involved in tubular albumin
reabsorption. Direct binding of labelled albumin to megalin
has previously been identified using Sepharose columns;83
however, an additional, high-affinity binding between
purified cubilin and megalin has been described in vitro.58
Based on this, it was suggested that megalin facilitates the
endocytosis and intracellular trafficking of cubilin.58 This is
further supported by studies showing that the in vitro uptake
of the cubilin ligands transferrin, Clara cell secretory protein
and apolipoprotein A-I/high-density lipoprotein is inhibited
by anti-megalin antibodies,84–86 as well as by megalin
antisense oligonucleotides.87 Thus, megalin may be involved
in albumin reabsorption directly as a receptor for albumin,
and/or indirectly by affecting the expression and/or endocytic
function of cubilin.70 Albumin uptake in OK cells is inhibited
by RAP, and by anti-megalin antibodies supporting this
notion. The inhibitory constant for RAP is 17 nM;82 however,
whether this reflects inhibition of albumin binding to cubilin,
to megalin, or cubilin–megalin interaction is unknown. So
far, RAP and albumin binding sites within the same region of
cubilin have not been identified.
It has been argued that the capacity of the megalin/
cubilin-mediated mechanism for tubular uptake of albumin
is low,9 and that the urinary albumin excretion in megalin-
defective mice and cubilin-defective dogs is only slightly
increased, representing merely a small increase in the
excretion of non-degraded albumin.9 It must be considered,
however, that megalin and cubilin are low-affinity albumin
receptors serving in a high-capacity, reabsorptive mechanism.
Assuming an albumin concentration of 10 mg/ml in the
ultrafiltrate, this is about one-fourth of the estimated Kd for
albumin binding to cubilin, and thus the tubular flow and the
length of the proximal tubule becomes important for the
amount of albumin reabsorbed. In mice and rats, with
relatively short proximal tubules, the fraction of reabsorbed
albumin compared to the filtered load is smaller than in
larger species with longer proximal tubules. Megalin
dysfunction caused a B1.5-fold increase in albumin excre-
tion in mice compared to a sevenfold increase in cubilin-
defective dogs,70 and up to 425-fold increase in Imerslund–-
Gra¨sbeck patients.77 The low affinity of albumin binding to
cubilin/megalin also implies that the amount of albumin
a b
Figure 2 | Immunocytochemical localization of cubilin and uptake
of endogenous albumin in cryosections of dog kidney cortex. In
normal dog kidney, (a) intense labeling for cubilin (green fluores-
cence) is observed at the luminal brush border and in endocytic
vesicles co-localizing with reabsorbed albumin (red fluorescence)
reflecting endocytosis of filtered protein. Apical vesicles reveal co-
localization of cubilin and albumin as indicated by the yellow label
(arrows in a). In dogs with a mutation in the AMN, gene-causing
defective insertion of cubilin into the apical membranes, (b) cubilin is
retained in intracellular vesicles and no evidence of endocytic uptake
of albumin is observed. Only a sparse labeling for albumin can be
identified in the tubular lumen and along the apical membrane, the
latter possibly reflecting binding to megalin (arrows in b). One
micrometer cryosections from perfusion fixed dog kidneys were
incubated with rabbit anti-dog cubilin (1:200) and sheep anti-rat
albumin (1:200) primary antibodies followed by incubation with Alexa
Flour 488 donkey anti-rabbit and Alexa Fluor 546 donkey anti-sheep
fluorescence labelled secondary antibodies. Bars¼ 10 mm.
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reabsorbed during heavy proteinuria with a high concentra-
tion of albumin in the ultrafiltrate may be much higher as the
reabsorbed amount is not limited by capacity, but rather by
the flow and concentration of albumin in the ultrafiltrate. An
important factor adding to the capacity of this system is the
constant and fast regeneration of receptors by membrane
recycling.88 Thus, the finding of only a small increase in
albumin excretion in cubilin- or megalin-deficient animals is
not inconsistent with the reabsorption and renal catabolism of
significant amounts of protein by the same receptors during
heavy proteinuria with filtration of large amounts of protein.
REGULATION OF TUBULAR ALBUMIN UPTAKE
Generally renal cubilin and megalin mediated tubular uptake
of proteins is considered a constitutive process regulated only
by changes in receptor expression levels identified in
conditions such as Dent’s disease, polycystic kidney disease
and possibly diabetes. Based on in vitro studies using OK
cells, it has been suggested that albumin uptake may be
regulated by G proteins,89 known to be involved in the
regulation of vesicular transport, by phosphatidylinositol 3-
kinase,90 and by protein kinases.91 Recently, it was shown that
protein kinase C induces ectodomain shedding of megalin,
also generated by the binding of the ligand vitamin D-
binding protein. It was suggested that this is accompanied by
the release of an intracellular domain, possibly involved in
intracellular signalling.92 The cytoplasmic tail of megalin has
been shown to interact with a number of cytoplasmic
proteins possibly modulating expression and/or function of
the receptor including the adaptor protein autosomal
recessive hypercholesterolemia27 and disabled protein 2
(Dab2).93–95 However, to what extent these potential,
regulatory mechanisms are part of an active pathway
regulating endocytosis in vivo is not known.
OTHER PATHWAYS
Alternative mechanisms of albumin reabsorption have been
suggested (Figure 3), including a fast, high-capacity retrieval
pathway for non-degraded albumin located distal to the
glomerular basement membrane.9,96 This hypothesis is based
on the analysis of the radioactive profile in renal venous
blood following pulse injection of 3H-albumin in the
isolated, perfused kidney.96 This revealed a second peak
interpreted as the rapid return of filtered, labelled albumin
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Lysosome
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Figure 3 | Pathways of albumin handling in the kidney. Albumin is filtered in the glomeruli (1) and reabsorbed by the proximal tubule cells
by receptor-mediated endocytosis (2a). Internalization by endocytosis is followed by transport into lysosomes for degradation. Classically, this is
considered to result in the formation of free amino acids released into the circulation (2b); however, it has been recently suggested that
significant amounts of albumin fragments are excreted in the urine, possibly resulting from tubular degradation of filtered albumin (2c). Some
intact albumin may escape tubular reabsorption (3), the amount being greater as the glomerular filtration fraction of albumin increases or
tubular function is compromised. The upper right shows a schematic representation of the intracellular pathways following endocytic uptake
of albumin and possible associated substances. Following binding to the receptors, cubilin or megalin, the receptor–albumin complex is
directed into coated pits for endocytosis, a process that may also involve AMN. The complex dissociates following vesicular acidification most
likely also leading to the release of any bound substances. Albumin is transferred to the lysosomal compartment for degradation. Some
albumin may be degraded within a late endocytic compartment and recycled as fragments to be released at the luminal surface. Alternatively,
albumin fragments may be recycled from the lysosomal compartment by a yet unknown route. Receptors recycle through dense apical tubules,
whereas released substances carried by albumin may be released into the cytosol or transported across the tubular cell. An alternative high-
capacity retrieval pathway for non-degraded albumin located immediately distal to glomerular basement membrane has been proposed (4);
but yet not characterized. Misdirected filtration of albumin into the interstitium resulting from pathological, glomerular changes has been
proposed as a pathway for progression of renal disease (5).
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with an estimated capacity of 400–500 g/24 h.9 While it was
suggested that micropuncture of early proximal tubule failed
to identify this process because of its location in the
glomerulus, or very early in the tubular system,96 the nature
of this proposed mechanism has not been established. It is
generally believed that tight junctions prevent paracellular
transport of most proteins,97–101 and so far, no morphologic
support for an alternative, transcellular albumin transport
mechanism has been demonstrated. Nevertheless, defects in
such a highly speculative, high-capacity albumin transport
pathway may result in heavy albuminuria without any initial
changes in glomerular function, and thus implicate a radical
change in our understanding of albuminuric renal disease.
ALBUMIN REABSORPTION AND INFLAMMATION
The concept of albumin-induced renal inflammation and
scarring has been intensively explored using both clinical and
experimental approaches. Albuminuria has been shown to be
an independent risk factor for the progression of renal disease
and the renoprotective effect of antiproteinuric treatment,
whether by dietary or pharmacological intervention, has been
shown to be correlated to the reduction in proteinuria.102,103
The hypothesis tested is that excess albumin in the tubular
lumen leads to the induction of inflammation, possible
tubular epithelial–mesenchymal transformation and inter-
stitial fibrosis. Overload albuminuria in rats and mice causes
interstitial inflammation and fibrosis.104,105 Studies on
proximal tubule cells have shown that albumin exposure
induces the expression of a number of inflammatory and
fibrogenic mediators, including cytokines such as RANTES
(regulated upon activation, normal T cell expressed and
secreted),106 monocyte chemotactic protein-1,107 interleukin-8,108
fractalkine109 and tumor necrosis factor-a,110 as well as
endothelin,111,112 transforming growth factor-b (TGF-b),112
collagen;113 and may also induce changes in tubular cell
expression of surface integrins114 or, eventually, apopto-
sis.115,116 These data suggest that albumin itself and/or bound
ligands such as fatty acids117–120 initiate a series of events that
eventually leads to fibrosis. The exact cascade has not been
established; however, evidence suggests that the process
involves the initial endocytic uptake of albumin. Renal cell
lines with low endocytic activity do not respond to albumin
by the activation of intracellular pathways and collagen
synthesis,113 and megalin-deficient cells appear to be less
sensitive to hemoglobin-induced proximal tubule necrosis.121
Interestingly, TGF-b, which may be induced by albumin
exposure,112 may also act in a feedback mechanism increasing
albumin filtration122 and at the same time inhibiting
megalin- and cubilin-mediated albumin endocytosis,123 both
leading to increased albuminuria.
Recent evidence indicates that albumin may interact with
signalling receptors including apically expressed EGF recep-
tors.124 In addition, it has been shown that members of the
low-density lipoprotein receptor family may be involved
directly in transmembrane signal transduction.125 The low-
density lipoprotein and very low-density lipoprotein recep-
tors, low-density lipoprotein receptor-related protein and the
apolipoprotein ER2, have been shown to bind other
cytoplasmic adaptor proteins, notably Dab1, at NPXY motifs
on the cytoplasmic tail of these receptors.126,127 Dab1 is part
of a signalling pathway involving the extracellular protein
Reelin important for brain development.128 So far, no specific
signalling events have been documented for megalin;
however, as previously mentioned, the cytoplasmic tail of
megalin has been shown to interact with Dab2,93,94 an
intracellular protein that may be involved in signalling or
regulating of cellular growth and differentiation.95 Recent
evidence also indicates signalling by ligand-induced, enzy-
matic release of a carboxyl-terminal fragment of megalin.92
Thus, it may be that excessive binding of filtered proteins,
including albumin, to megalin may initiate intracellular
signalling events. Proposed intracellular signalling cascades
include the activation of nuclear factor kb110,129–133 as well as
STAT (signal transducers and activator of transcription)134
transcription factors, possibly through the formation of
reactive oxygen species,131,134 a process that may also be
dependent on protein kinase C.131 Interestingly, delipidated
albumin has been suggested to protect against reactive
oxygen species,135 indicating that the potentially protective
versus damaging effect is determined at least, in part, by the
substances carried by albumin.136 In addition to albumin,
several other filtered proteins have been suggested to induce
proximal tubule phenotypic changes, including iron carriers,
proteins of the complement system, immunoglobulins, and
growth factors. It is not clear to what extent each of these
proteins or their combination contributes to the inflamma-
tion and fibrosis; however, some studies indicates differential
and protein-specific effects,137,138 and studies in analbumi-
nemic rats even suggested that albumin was not important to
the progression of proteinuric, renal disease when evaluated
for up to 20 weeks.139,140
Most of the studies exploring the mechanism of
proteinuria-induced renal changes are based on proximal
tubule cell lines. Cells are exposed to albumin or serum
fractions and changes are studied by protein and gene
analysis of the media and/or the cells. It is obvious that
extrapolation from such data to the human in vivo situation
may be difficult also considering the somewhat conflicting
data observed with different proteins in different cell
systems,116,137,138 as well as the reported changes in the
expression of several genes of still unknown function.141 The
obvious challenge to the overall hypothesis is the ability to
specifically interfere with the cascade of events leading to
irreversible renal damage. An established approach has been
to prevent or reduce proteinuria notably by blocking the
renin–angiotensin system.142 Another approach would be to
inhibit tubular uptake of proteins either by blocking binding
to receptors or by inhibiting endocytosis. As both megalin
and cubilin are multiligand receptors serving other important
functions, for example, for the uptake and metabolism of
vitamins,37 including the activation of vitamin D,143,144 this
approach may prove inappropriate. Recently, it has been
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shown that transfection with a monocyte chemotactic
protein-1 antagonist145 or a truncated form of IkBa, thereby
inhibiting nuclear factor-kb,133 inhibits albumin-overload
induced tubulointerstitial injury supporting the possibility of
therapeutic intervention at the tubular level. Additional
evidence suggests that inhibition of the renin–angiotensin
system in addition to a reduction of proteinuria may also
attenuate albumin-induced signal activation in tubular
cells.146 Further studies should evaluate the clinical signifi-
cance and feasibility of the various approaches.
An alternative hypothesis to explain the progression of
renal disease has been proposed based on histological studies
of the development and progression of animal and human
renal disease.147 The analyses revealed differential changes in
glomerular structure, including adhesions of the glomerular
tuft to Bowman’s capsule causing the formation of crescents,
either by misdirected filtration or by epithelial cell prolifera-
tion. It was suggested that progression of injury into the
tubulointerstitium is caused by direct encroachment of the
glomerular disease either by misdirected filtration into the
space between the tubular epithelium and basement mem-
brane (Figure 3)148,149 or by incorporation of the initial
proximal tubule into the growing cellular crescent.149 In both
cases, this results in the loss of nephrons and subsequent
fibrosis, which is considered a reparative process important
for the maintenance of renal structure rather than a
determinant of further injury.147 While this hypothesis does
not exclude a direct effect of proteins, including albumin,
filtered into the tubular lumen, it is clear that the approach to
prevent progression of renal disease according to this
hypothesis should be aimed at the glomerular changes rather
than the tubular reactive processes.
CONCLUSIONS
Ample evidence suggests an association between the
progression of renal disease and albuminuria reflecting an
imbalance between glomerular filtration and tubular
reabsorption of this protein. Modulation of the renin–angio-
tensin system has proven to reduce proteinuria and to
attenuate the progression of renal disease. In vitro studies
show that albumin induces changes in tubular cells
stimulating the expression of inflammatory and fibrogenic
mediators. Although inflammation appears to be an
important pathogenic factor in a number of renal diseases
characterized by albuminuria, the possible pathogenic role of
albumin itself, however, is not fully elucidated. An attractive
hypothesis consistent with the in vitro observations suggests
that an initial glomerular dysfunction causing filtration of
increased amounts of albumin and other potential
proinflammatory proteins is followed by proximal tubule
reabsorption and the induction of inflammation and,
eventually, fibrosis mediated by the tubular cells. Whether
this mechanism is important to the pathophysiology of
human renal disease remains to be established, urging the
need for means to specifically intervene at specific steps in
this pathway.
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